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Abstract
Introduction: As providing health education, optimizing nutrition, and managing risk factors can be effective for
ensuring a healthy outcome for women and her yet un-conceived baby, external influences play a significant role as
well. Alcohol, smoking, caffeine use and other similar lifestyle factors, have now become an integral part of the daily life
of most men and women, who use/misuse one or more of these harmful substances regularly despite knowledge of
their detrimental effects. The adverse health outcomes of these voluntary and involuntary exposures are of even greater
concern in women of child bearing age where the exposure has the potential of inflicting harm to two generations.
This paper is examining the available literature for the possible effects of caffeine consumption, smoking, alcohol or
exposure to chemicals may have on the maternal, newborn and child health (MNCH).
Methods: A systematic review and meta-analysis of the evidence was conducted to ascertain the possible impact
of preconception usage of caffeine, tobacco, alcohol and other illicit drugs; and exposure to environmental
chemicals and radiant on MNCH outcomes. A comprehensive strategy was used to search electronic reference
libraries, and both observational and clinical controlled trials were included. Cross-referencing and a separate
search strategy for each preconception risk and intervention ensured wider study capture.
Results: Heavy maternal preconception caffeine intake of >300mg/d significantly increase the risk of a subsequent
fetal loss by 31% (95% CI: 8-58%). On the other hand, preconception alcohol consumption leads to non-significant
30% increase in spontaneous abortion (RR 1.30; 95% CI: 0.85-1.97). Preconception counselling can lead to a
significant decrease in the consumption of alcohol during the first trimester (OR 1.79; 95% CI: 1.08-2.97).
Periconception smoking, on the other hand, was found to be associated with an almost 3 times increased risk of
congenital heart defects (OR 2.80; 95% CI 1.76-4.47). While the review found limited evidence of preconception
environmental exposure on maternal, newborn and child health outcomes, occupational exposure in female
radiation workers before conception showed an increased impact in risk of early miscarriages.
Conclusion: Identification of substance abuse and environmental history during preconception period provides an
opportunity to assist women in reducing major health risks and identify key determinants of healthy pregnancy.
Studies have shown that the aversion and prevention of exposure feasibility can play an important role in improving
the health of women and their families, however, the results should be interpreted with great caution as there were
few studies in each section. Therefore, there is a need for more rigorous studies to test the hypotheses.
Introduction
While factors like maternal nutritional status, disease
control and reproductive planning are critical in ensuring
a healthy outcome for women and their future offspring,
exposure to drugs and chemicals play a significant role
as well. Alcohol, smoking, caffeine use and other similar
lifestyle factors, have now become an integral part of
the daily life of most men and women, who use/misuse
one or more of these harmful substances regularly
despite knowledge of their detrimental effects. Exposure
to reproductive and developmental toxicants in the envir-
onment (at home and at the workplace) is of concern.
The adverse health outcomes of these exposures are of
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even greater concern in women of child bearing age
where the exposure has the potential to inflict harm to
her baby in utero as well.
Alcohol is a known teratogen and prenatal alcohol use
is an important preventable cause of maternal morbidity
and neonatal birth defects and developmental disabilities.
A recent National Survey on Drug Use and Health [1]
quoted rates of current alcohol use to be 57% in adult
females and rates of binge drinking (≥5 drinks on the
same occasion) to be approximately 25% in the United
States. Smoking is another factor that leads to known
maternal and fetal complications during pregnancy and
almost one third of women of child-bearing age smoke
[1]. Exposure to caffeine during pregnancy has been asso-
ciated with an increased risk of spontaneous abortion and
low birth weight [2]. Often, these habits begin during
adolescence, only to be consolidated as young men and
women become adults. Many young women continue to
be exposed to these harmful substances during the first
trimester without realizing they are pregnant, exposing
the fetus to the toxic effects of substance use during
organogenesis, resulting in long-lasting effects on the
child’s physical and mental development. Alcohol,
tobacco and illicit drug use are often so deeply engrained
that many continue use even during pregnancy as shown
by the National Survey of Drug Use and Health
(NSDUH) survey. The survey reported that almost 11%
of the pregnant women stated current alcohol use and
5% of pregnant women use some form of illicit drugs [1].
More than 80% of pregnant women also attested to con-
suming some form of caffeine in another study [3].
Alongside these, there are environmental and occupa-
tional hazards with teratogenic potential and a woman’s
professional and residential activities may pose risks for
her before pregnancy. These are not limited to work-
related exposures to radiation, but also encompass con-
tact with substances like lead in paints, mercury from
consumption of seafood, or pesticides in the soil.
These risks and the interventions to prevent and avoid
them are an important component of preconception care.
In this review, preconception care is defined as “any inter-
vention provided to women and couples of childbearing
age, regardless of pregnancy status or desire, before preg-
nancy, to improve health outcomes for women, newborns
and children”. Periconceptional care, on the other hand, is
any intervention provided to women of childbearing age
preceding conception but that continues into the first tri-
mester, to improve health outcomes for women, newborns
and children [4].
This systematic review was conducted to synthesize the
evidence linking each of these potentially avoidable risk
factors during preconception period and their impact on
maternal, newborn and child health (MNCH) outcomes.
The review also identified and assessed the impact of
interventions for avoiding the usage of caffeine, tobacco,
alcohol and other illicit drugs; and exposure to environ-
mental or workplace chemicals and radiation that have
shown promising results on MNCH.
Methods
This paper systematically reviewed all the literature pub-
lished up to 2011 to identify studies describing the effec-
tiveness of preconception risks and intervention to
prevent and avoid substance abuse and environmental
and workplace exposure to chemicals and radiations for
improved maternal, newborn and child health (MNCH)
outcomes. Electronic databases such as PubMed,
Cochrane Libraries, Embase, and WHO Regional Data-
bases were searched to identify the experimental and
observational studies on the subject. Papers were also
identified by hand searching references from included
studies. No language or date restrictions were applied in
the search. The findings were presented at international
meeting [5,6]and shared with professionals in the rele-
vant fields of maternal and child health, following which
results were updated based on current searches (through
end of 2012) and expert opinion. Studies were included
if they reported the effectiveness of interventions for
and risks to substance abuse and environmental expo-
sure on MNCH outcomes. The methodology is
described in detailed elsewhere [4].
Two authors assessed the eligibility of studies and
extracted data and judged the quality on standardized
sheets. The quality of experimental studies were
assessed using Cochrane criteria [7], whereas STROBE
guidelines were used to assess the quality of observa-
tional studies [8]. We conducted meta-analyses for indi-
vidual studies and pooled statistics was reported as the
odds ratio (OR) and relative risk (RR) between the
experimental and control groups with 95% confidence
intervals (CI). Mantel–Haenszel pooled RR and corre-
sponding 95% CI were reported or the Der Simonian–
Laird pooled RR and corresponding 95% CI where there
was an unexplained heterogeneity. Since most of the
studies were observational in design, therefore, we used
generalized inverse variance (GIV) method to pool data
which is a better way to run a comparative analysis [9].
All analyses were conducted using the software Review
Manager 5.1 [10]. Heterogeneity was quantified by Chi2
and I2, in situations of high heterogeneity, causes were
explored through sub-group analysis and random effect
models were used.
Results
The search identified 1491 papers. After the initial title
and abstract screening, 40 full texts were reviewed to
assess which papers met the inclusion criteria and had
the outcomes of our interest. Thirty nine studies were
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finally selected for abstraction and analysis (Figure 1). On
quality assessment, observational studies often had inade-
quate description of the quantitative exposure, and
instead categorized exposure as high versus low with
variable cutoffs used in each study. Studies had limited
quality with respect to statistical analysis and adjustment
for confounders. Overall studies were of moderate qual-
ity. The quality of intervention studies was compromised
with respect to selection, performance and reporting bias.
Information related to each included study can be found




With regards to preconception caffeine intake, some
studies have concluded that a high daily intake of caf-
feine prior to pregnancy leads to an increased risk of
spontaneous abortion [2,11,12] while others reported no
association [13-15].
A total of six observational studies (3 prospective and 2
retrospective) [2,11,12,16-18] were identified on the effect
of preconception caffeine intake on fetal loss. Of these,
5 were included in meta-analysis as one study [11] failed
to provide data on the quantity of caffeine ingested. The
review categorized the level of caffeine intake into
>300mg/day, >420mg/day and >900mg/day and compared
with an intake <150mg/day. Caffeine intake was found to
be significantly associated with fetal loss: >300mg/day
(RR 1.31; 95% CI: 1.08-1.58), intake >420mg/day (RR 6.11;
95% CI: 5.12-7.29) and >900mg/day (RR 1.72; 95% CI:
1.00-2.96). Although the forest plot cannot be interpreted
for a dose-response relationship due to limitations with
regards to a comparison group (mentioned in the forest
plot), each individual study had reported a non-significant
increase in risk of spontaneous abortion with daily
increased caffeine consumption (Figure 2).
Alcohol intake
Prenatal alcohol exposure is associated with sponta-
neous abortion, prenatal and postnatal growth restric-
tion and birth defects [19-21]. It is one of the leading
causes of neurodevelopmental deficits in children in the
United States, as a result of fetal alcohol spectrum disor-
der (FASD) [22-26].
Population-based behavior modification interventions
(reduction of alcohol use and improved contraception)
in women of child-bearing age show promise [27-29].
Content of preconception care for reducing alcohol
intake includes screening of all women of reproductive
age, intervention for those who are consuming it exces-
sively (>7 drinks/week or > 3 drinks on 1 occasion),
counseling about the adverse effects on pregnancy out-
comes, promotion of abstinence programs for those with
Figure 1 Search flow diagram
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alcohol dependency and encouragement of consistent
contraceptive use for those not in control of their drink-
ing habits.
The review identified eight [2,19,30-36] risk aversion and
two intervention studies [29,37] dealing with both pre- and
periconception drinking as well as interventions during
these same periods to alter drinking behavior among
women. The analysis showed a non-significant 30%
increase in the risk of occurrence of spontaneous abortions
with preconception alcohol consumption (Figure 3).
Another study [30] displayed a non-significant
increased odds of neural tube defects (NTDs) with pre-
conception alcohol intake (OR 1.24; 95% CI: 0.92-1.68),
while preconception binge drinking was associated with
20% greater risk of NTDs when compared with alcohol
intake of 1 drink/day. Periconception alcohol consump-
tion was also found to be associated with esophageal
atresia with or without tracheo-esophageal fistula (RR
1.26; 95% CI: 1.03-1.56). While Carmichael et al. [33]
did not find any association of periconceptional alcohol
exposure with congenital heart defects (OR 0.96; 95%
CI: 0.91-1.01), Mullany et al. [38] displayed a non-signif-
icant increased risk of conotruncal heart defects with
alcohol intake once weekly (RR 1.6; 95% CI: 0.8-3.0)
compared to none.
The review also found an association of preconception
substance abuse with depression [36]. Analysis showed
higher rate of depression among alcohol users however
the rates of depression increased with combined use of
alcohol and other drugs compared to when alcohol was
taken alone (RR 1.94; 95% CI: 1.38-2.73).
Preconception counselling [37] led to a significant
decrease in the consumption of alcohol during the first tri-
mester (OR 1.79; 95% CI: 1.08-2.97) however the decrease
in binge drinking episodes (OR 1.51; 95% CI: 0.63-3.62)
was not significant. There was no association of precon-
ception counselling and continuing to drink through the
rest of pregnancy (OR 0.95; 95% CI: 0.59-1.53). Another
paper [29] found an impact on reducing the rates of alco-
hol exposed pregnancy (AEP) amongst those who con-
sumed more than 8 drinks per week through motivational
interviewing. On three months follow up the odds of
being at reduced risk of AEP was 2.31 (95% CI 1.69-3.20);
at 6 months the odds was 2.15 (CI1.52-3.06); and at
9 months the odds was 2.11 (CI1.47-3.03). This interven-
tion also led to a significant increase in the use of effective
contraception (OR 2.18; 95% CI: 1.80-2.64) thereby signifi-
cantly reducing the risk of an AEP (OR 2.20; 95% CI: 1.81-
2.68). This finding was in accordance to the results of
another trial [28] of a behavioural intervention where 74%
Figure 2 Periconception caffeine intake and risk of spontaneous abortions: evidence from observational studies
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of women were no longer at risk for AEP at 1 month post-
intervention (Figure 4).
Pre and Peri conception smoking
Fetal effects of exposure to maternal smoking include
intrauterine growth restriction (IUGR), prematurity, LBW,
congenital malformations [39-44] and sudden infant death
syndrome [45]. In the past two decades many clinical trials
have demonstrated the effectiveness of smoking cessation
interventions in early pregnancy [46].
The content of preconception care for women who
smoke includes: screening of all women of child-bearing
age using evidence-based guidelines, treatment of depen-
dence before planning a pregnancy, informing women
about the adverse pregnancy outcomes associated with
tobacco consumption, discussion of possible interventions
to assist in quitting (including the use of medications) and
referring to intensive counseling services where necessary.
The review identified seven risk aversion studies
[30,32,34,35,47-50] and one intervention study [37] on the
effect of preconception smoking cessation. A study by Haas
et al. [47] showed that preconception smoking was signifi-
cantly associated with preterm births (OR 2.2; 95% CI:
1.29-3.75). On the other hand, no impacts were seen on
orofacial defects (OR 1.17; 95% CI: 0.89-1.52) [32,34,48]
and NTDs whether the consumption was greater or less
than a pack per day (OR 0.80; 95% CI: 0.59-1.08) [30].
Periconception smoking was significantly associated
with 3 folds increased risk of congenital heart defects (OR
2.80; 95% CI 1.76-4.47) (Figure 5) [49], while no associa-
tion was found between exposure and esophageal atresia
with or without tracheoesophageal fistula (RR 0.95; 95%
CI: 0.76-1.19) [31] and congenital diaphragmatic hernia
(OR 1.10; 95% CI: 0.91-1.33) [35].
On comparing light smoking (<14 cigarettes/day) with
heavy (>25 cigarettes/day) in the periconception period
Figure 3 Preconception alcohol intake and risk of Spontaneous abortions: evidence from observational studies
Figure 4 Post intervention reduction in risk drinking and improvement in effective contraception use, thereby leading to a reduction in Alcohol
pregnancy: evidence from controlled trial
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(1 month before pregnancy till the end of the 1st trime-
ster), light smoking was associated with non-significant
17% lower risk of heart defects than heavy smoking (RR
0.83; 95% CI: 0.65-1.07) [32]. On assessing the effect of
preconception parental smoking on the risk of childhood
leukemia, it was seen that paternal smoking was signifi-
cantly associated with a greater risk (OR 0.99; 95% CI:
0.66-1.47), whereas, maternal smoking was not associated
with risk of developing leukemia in the childhood period
(OR 0.99; 95% CI: 0.66-1.47) [50].
The review identified one intervention study that com-
pared the effectiveness of preconception counseling with
standard care and found 3 times greater likelihood of
women quitting smoking in the post-intervention group,
although the association was not statistically significant
(2.94; 95% CI: 0.70-12.36) [37].
Illicit drugs consumption
Maternal substance abuse is associated with pregnancy
complications, LBW, an increased risk of infant mortality,
neonatal abstinence syndrome, ineffective parenting tech-
niques, child abuse and neglect, and possible increased
likelihood of human immunodeficiency virus (HIV) trans-
mission. Substance abuse also is often associated with
other social and health problems that affect both the
mother and infant, including domestic violence, poverty,
homelessness, sexual abuse, psychiatric disorders, and
poor health care [51].
The review aimed to assess the effects of preconception
abuse of illicit drugs and possible interventions to reduce
the level of abuse amongst women of reproductive age
before conception Preconception care includes identifica-
tion of women who are consuming illicit drugs, counseling
on the risks associated with preconception use of various
drugs, informing about programs that support abstinence
and treatment and promoting the importance of contra-
ception until cessation of use is achieved.
The review found a limited number of risk aversion
[30,36,52,53] and intervention studies [54,55] concerned
with the MNCH effects of periconception substance abuse.
Paternal periconception use of illicit drugs overall did not
have an association with the risk of NTDs (RR 1.07; 95%
CI: 0.87-1.31) [30], however a significant association was
found with heroin use alone (RR 1.63; 95% CI: 1.23-2.16).
Maternal use of recreational drugs during the periconcep-
tion period had no impact on occurrence of NTDs (RR
0.91; 95% CI: 0.77-1.07) [30,52] (Figure 6). Comparing par-
ental use (combined or individual) versus no use did not
yield any significant association with NTD risk [30].
A strong association was found between recreational
drug use in the month in which conception occurred
and incidence of gastroschisis, although this evidence
came from a single case-control study (OR 1.76; 95% CI:
0.99-3.13) [36]. A significant association was also found
between substance abuse before pregnancy and maternal
depression (OR 9.60; 95% CI: 1.80-51.20) [53].
Amongst the two interventional studies, one studied the
health seeking behavior of substance-abused women using
the ‘Steps of Change’ model [54]. The other compared the
effect of behavioral couple’s therapy (BCT) with indivi-
dual-based therapy (IBT) amongst substance-abusing men
and assessed its impact on incidence of partner violence
[55]. It reported that post-intervention, male-to-female
aggression in the BCT group was lower than in the IBT
group (17% vs. 43%). Also husbands in the BCT group
reported fewer days of drug use, longer episodes of absti-
nence, and less drug-related hospitalizations or arrests.
Ameliorating environmental exposures
Radiation exposure
Ionizing radiation is known to have harmful effects on the
reproductive systems of both males and females [56]. It is
one of the few known factors to increase the likelihood of
childhood cancers. The danger to the embryo and fetus of
intrauterine ionizing radiation exposure is well documented
[57,58]. While some studies have found a significant associa-
tion between preconception paternal exposure to ionizing
radiation and non-Hodgkin’s lymphoma in their children
[59-61] others found a weak, non-significant association [62]
or no association at all [63-67]. Studies have also shown a
significant elevated risk of childhood cancers in children
born to exposed female radiation workers [60,61].
Figure 5 Periconception maternal smoking and risk of congenital heart defect: evidence from observational studies
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Ionizing radiation exposure is composed of both, occu-
pation-related exposure as well as non-occupational expo-
sure. The content of preconception care with respect to
environmental exposures consists of taking a detailed his-
tory of the couple to identify possible sources of radiation
exposure, informing women of child-bearing age about
the possible deleterious effects (miscarriage, stillbirths,
childhood cancer) of such exposure, on their health as
well as that of the fetus, especially during the time where a
woman does not yet know she is pregnant.
Both occupational [62,68,69] and non-occupational
[33,34,70] radiation exposure were analyzed separately.
One reported the effect of preconception occupational
radiation exposures in women on fetal death [68]. This
study showed an increased risk of early miscarriage in
mothers who were exposed to radiation in the workplace
(RR 1.32; 95% CI: 1.04-1.66). This association was stronger
in women who were monitored within 6 months of con-
ception (RR 1.50; 95% CI: 1.20-1.87) . There was also a
non-significant association with stillbirths a (RR 2.30; 95%
CI: 0.80-6.62) and second trimester miscarriage (RR 0.50;
95% CI: 0.20-1.26) [68].
Both paternal and maternal exposure to preconception
ionizing radiation at work led to an overall greater risk
of childhood cancers (RR 1.29; 95% CI: 1.02-1.63; and
RR 1.19; 95% CI: 0.92-1.54 respectively) (Figure 7 and
Figure 8), however this association was only significant
for maternal exposure. This finding is not in conjunc-
tion with the results of Bunch et al. [71] on the effect of
preconception maternal radiation exposure on all child-
hood cancers (RR 1.90; 95% CI: 0.84-4.58). However, on
pooling these studies, a significant association between
exposure and outcomes was found (RR 1.33; 95% CI:
1.06-1.67). Studies looking at the effect of radiation dose
on the incidence of childhood hematological malignan-
cies had equivocal results [60,62,67,72-74]. However,
many had samples too small to comment on the signifi-
cance of their findings.
Non-occupational exposure to ionizing radiation via X-rays
is associated with higher rates of adverse fetal and neonatal
outcomes. Paternal exposure is associated with low mean
birth weight (MD -73.00; 95% CI: -78.97, -67.03) [70] and
reduced intrauterine growth (MD -53.00; 95% CI: -58.21,
-47.79) [70]. There was no data available for possible effects
of maternal preconception exposure on these outcomes.
Parental X-ray exposure before conception also had an asso-
ciation with childhood cancers, especially between paternal
abdominal exposure and leukemia in the offspring [62].
Chemical exposure
An increasing body of scientific research provides discon-
certing verification of the potential impact of environmental
Figure 6 Maternal periconception consumption of illicit drugs and risk of NTDs: evidence from observational studies
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toxins that greatly affect human reproductive health and
human development. It is believed that roughly 3% of fetal
developmental defects are attributable to chemical expo-
sures [75]. Toxic chemical exposures include organic sol-
vents, metals, pesticides, polychlorinated biphenyl (PCB).
Adverse outcomes associated with chemical exposures
include LBW [76], spontaneous abortion, preterm birth,
stillbirth/infant death, congenital anomalies [77], develop-
mental delays [78], and childhood cancers [79].
This section reviewed literature for effects of exposure
among either parent in the preconception period on the
subsequent pregnancy and its outcomes. Early spontaneous
Figure 7 Preconception maternal exposure to radiation and childhood cancer: evidence from observational studies
Figure 8 Preconception paternal exposure to radiation and childhood cancer: evidence from observational studies
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abortions were defined as <12 weeks of gestation; >12
weeks but <20 weeks of gestation was classified as late
spontaneous abortion. The content of preconception care
with respect to environmental exposures consists of taking
a detailed history of the couple to identify possible sources
of toxic exposure, informing women of child-bearing age
about the deleterious effects of such exposure, at home or
at the workplace, on their health as well as that of the fetus,
in case of an unknown pregnancy status.
The review found very limited evidence [80-89]
regarding parental toxic exposure and effects on MNCH
outcomes. Preconception exposure to pesticides was
associated with 27% increase in spontaneous abortions
(p <0.001); 31% increase in early spontaneous abortions
(p=0.0007) and 22% increase in late spontaneous abor-
tions (>12 weeks) (p=0.03) [80]. Paternal exposure to
pesticides in the year before conception also showed an
increase in the rates of hematological malignancies in
their offspring [90-94].
Analysis of studies on parental exposure to chemicals
like paints, solvents, industrial products etc. showed a
10% (p=0.02) increase in the risk of acute lymphoblastic
leukemia (ALL) in subsequent offspring , similarly, the
risk of ALL was 44% higher with maternal exposure
(p<0.001) [81,82]. McKinney et al. [83] also found that
exposure to dermal hydrocarbons and metal during the
preconception period was linked to an increased risk
ofleukemia and ALL. Vincetiet al. [84] reported an
excess risk of cardiovascular defects (OR 2.59; 95% CI:
1.68-3.82) in a lead-polluted area.
Women who reported using wood to cook during the
the periconception period had 3 folds increased risk of
having infants with a NTD (95% CI:1.70-6.21) [85].
Another study reported that women who used wood,
coal or tires in their home for cooking or heating had
twice the odds of having a child with anencephaly com-
pared with women not using this kind of fuel (OR 2.04;
95% CI: 1.29-3.23) [86].
Another area of unavoidable environmental exposure
is that of traffic-related particulate air pollution. Perin et
al.[87] showed that the risk of early pregnancy loss in
women exposed to high levels of ambient particulate
matter (>56.72 mg/m3) during the preconceptional per-
iod was almost 3-fold higher compared to women
exposed to lower levels. The review also found evidence
on the effect of bed-heating devices on the occurrence
of certain birth defects (NTDs and orofacial defects),
none of which were significant [88].
Discussion
A growing number of women in their reproductive years
continue to consume caffeine, alcohol, tobacco or illicit
drugs. Moreover, increasing evidence from observational
and epidemiological studies is supporting the linkages of
harmful environmental exposures with human health
and reproduction. While it is distressing that women
(and men) continue to put themselves at risk, it is there-
fore important that measures should be taken to amelio-
rate these risk factors. This review found that heavy
preconception caffeine consumption of >300mg/d signif-
icantly increased the risk of subsequent fetal loss by
31%. However, the association and mechanism by which
caffeine intake affects MNCH outcomes is still not
understood. Further research is also needed to assess
the link between pre-gestational use of caffeine and
spontaneous abortion. More specific research may help
to elaborate on this in order to find a relatively safe cut-
off. Preconception care, therefore, requires early identifi-
cation of women who consume caffeine more than occa-
sionally. Such women need to be informed of the
potential risks of adverse pregnancy outcomes associated
with caffeine intake (spontaneous abortion, low birth-
weight). Cutting down to minimal or no caffeine intake
should be the goal well in advance of a conception.
Although a positive pregnancy test may lead to a signifi-
cant decrease in the alcohol use of many women, the inter-
vening time lapse between that and conception are critical
periods of fetal susceptibility to alcohol while the develop-
ment of major organs is occurring. Alcohol consumption
before or around the time of conception is linked to multi-
ple adverse fetal outcomes including spontaneous abortion,
gastrointestinal malformations and NTDs. None of
these associations reach a level of statistical significance.
Pre-pregnancy alcohol consumption is also correlated with
maternal depression. Both preconception counselling as
well as behavioural interventions have led to a significant
improvement in drinking behaviour and thus pregnancies
affected by alcohol. It is now required to use this important
information to upgrade these interventions to have stron-
ger, longer-lasting and more widespread effects.
Women, who are habitual smokers, put their health
and that of their unborn child in jeopardy, as precon-
ception and peri-conception smoking significantly
increase the threat of preterm births by twice as much
and also raises the risks of congenital defects in the
fetus. In order to reduce the chances of the adverse
effects delineated above, effective interventions for
women of reproductive age who smoke should be
implemented during preconception period and at a large
scale. Although preconception counseling does improve
practices in women pertaining to their smoking habits,
behavioral interventions in synergy with general precon-
ception counseling may play a more significant part.
Hence it is important to motivate women of reproduc-
tive age to quit smoking before they conceive. Substan-
tial research literature exists for interventions to quit
smoking cessation among adults, women in general and
pregnant women, however there is a dearth of clinical
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studies focusing specifically on non-pregnant women of
childbearing age.
On the other hand, the current literature available to
study the effect of preconception parental exposure to
ionizing radiation on MNCH outcomes is limited, espe-
cially for fetal and early neonatal effects. The analyses
showed some association of maternal exposure to radiation
with early miscarriages and childhood cancers, and pater-
nal exposure to X-ray with increased cases of childhood
cancer.
In conclusion, there was a paucity of literature on the
MNCH effects of exposure to various environmental
agents in the preconception period. Although our data
suggests a significant effect of preconception pesticide
exposure on all spontaneous abortions and of preconcep-
tion exposure to other chemicals (solvents, paints, indus-
trial dust etc.) on the risk of ALL in their offspring, these
results should be interpreted with great caution as only a
small amount of relevant studies were pooled and ana-
lyzed. This clearly delineates the work for future research
as countless environmental agents still need to be studied
for their effects on MNCH outcomes. Only then will com-
prehensive interventions to reduce exposure be designed
and evaluated for a final formation of a sound policy deal-
ing with this topic. They should be advised to avoid eating
shark, swordfish, king mackerel, and tile fish to reduce
possible exposure to mercury. Women with a history of
lead poisoning should be counseled on the risk on the
unborn child.
The review found paucity of studies conducted in pre-
conception period and reported MNCH outcomes. The
number of experimental studies was too few and majority
of the included studies were observational in nature.
Although the association was studied well, there were
small number of studies in each section and their quality
was compromised. Therefore, the results from this review
should be interpreted with great caution. The complete
description of the exposure was also not reported in each
study and the categorization of dosage of intake and sever-
ity of exposure varied across all the studies. Another lim-
itation was the description of timing of exposure. Studies
reported maternal or paternal preconception exposure,
but failed to underscore the exact time and duration.
Therefore, there is a need for more rigorous studies to test
the hypotheses. With the rising epidemiological trends of
smoking, alcohol and illicit drugs consumption in low and
middle income countries, it is important that more studies
should be conducted in these countries as well.
Conclusion
Use of caffeine, alcohol, and other illicit drugs and expo-
sure to environmental exposure to radiation and chemical
solvents put a significant health risks to the health of
women and their children. Identification of substance
abuse and environmental history during preconception
period provides an opportunity to assist women in redu-
cing major health risks and identify key determinants of
healthy pregnancy. Studies have shown that the aversion
and prevention of exposure feasibility can play an impor-
tant role in improving the health of women and their
families.
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